Dabur India Q2 FY27 Revenue Rises 11.6% to ₹3,563 Crore
Key highlights
- Dabur India Ltd reported Q2 FY27 consolidated revenue of ₹3,563 crore, up 11.6% year on year.
- Consolidated profit after tax rose 11.7% year on year to ₹505 crore in Q2 FY27.
- India FMCG revenue grew 10.7%, with volume growth of 5.5% in Q2 FY27.
- Dabur declared an interim dividend of ₹3.50 per share and reported a 60-basis-point operating-margin contraction.
powered by IRIS
Dabur India Ltd reported consolidated revenue of ₹3,563 crore in Q2 FY27, up 11.6% year on year, while profit after tax increased 11.7% to ₹505 crore despite commodity inflation and international market volatility.
Know Dabur India inside out
Results, valuation, peers and who's buying, in one view.
What did Dabur India report for Q2 FY27?
Dabur India Ltd reported a broad-based increase in revenue and profit for the quarter ended September 30, 2026. Consolidated revenue rose 11.6% year on year to ₹3,563 crore, while consolidated profit after tax grew 11.7% to ₹505 crore. Consolidated operating profit increased 7.5% to ₹633 crore.
The operating-margin performance was less favourable than the revenue and profit growth figures. Dabur said its consolidated operating margin contracted by 60 basis points during the quarter. The company had flagged pressure from inflation in key input categories, particularly within Home and Personal Care and OTC & Ethicals, in its quarterly business update issued on October 6.
The standalone business recorded revenue of ₹2,433 crore, an increase of 8.9% year on year. Standalone profit after tax rose 11.2% to ₹388 crore. India FMCG revenue grew 10.7%, supported by 5.5% volume growth, while international revenue increased 20.0%.
How did Dabur India's quarterly performance develop?
Dabur's October quarterly update had indicated that consolidated revenue would grow at a double-digit pace and that India FMCG would return to double-digit growth. The final reported figures showed consolidated revenue growth of 11.6% and India FMCG revenue growth of 10.7%, consistent with that preliminary assessment.
The company had identified Home and Personal Care as a growth driver before the results. It expected the segment to post double-digit growth, with Hair Oils and Shampoos projected to deliver high-teens growth. Dabur said the performance was supported by demand for both perfumed and coconut hair oils, and noted that this represented the fourth consecutive quarter of double-digit growth for these categories.
Demand conditions were described as steady despite a difficult operating environment. Dabur cited renewed geopolitical tensions in the Middle East, elevated inflation across several commodities and deficit rainfall as factors affecting the quarter. These conditions had the potential to affect both consumer demand and input costs, particularly in businesses dependent on agricultural and commodity-linked materials.
Management said calibrated price increases and cost-saving actions partly offset the margin impact of inflation. However, the 60-basis-point contraction in consolidated operating margin shows that these measures did not fully absorb the increase in costs during the period.
Got a follow-up? Ask IRIS
What corporate actions accompanied the Q2 FY27 results?
Dabur's board approved the Q2 FY27 financial results on November 4, 2026, and declared an interim dividend of ₹3.50 per share. The company also noted National Company Law Tribunal approval for the amalgamation of Sesa Care.
The company filed its Q2 FY27 investor presentation with the exchanges on the same date. This presentation outlined the quarterly financial performance and the outlook for FY27, including the demand and cost conditions affecting its India and overseas operations.
Dabur has also scheduled an in-person analyst and institutional investor meet in Mumbai at 4:00 p.m. IST on November 5, 2026. The company said the meeting would discuss Q2 FY27 business performance and that no separate earnings call would take place after the September-quarter results. The presentation is to be filed with stock exchanges and made available on the company's website.
The sequence follows Dabur's earlier communication that detailed quarterly results and an earnings presentation would follow board approval. Its October update had focused on operational trends rather than presenting the complete financial statements.
How did the results affect investors and Dabur's market position?
Dabur shares had risen 4% in Tuesday's trade after the company stated that it expected double-digit consolidated revenue growth for the September quarter. That market move occurred after the preliminary update on business trends, before the detailed Q2 FY27 figures were released.
For investors, the reported results provide confirmation that revenue and profit after tax both achieved double-digit year-on-year growth. The 5.5% India FMCG volume growth is also relevant because it indicates that a part of domestic revenue growth came from higher sales volumes rather than pricing alone. At the same time, the lower operating margin remains an important measure of the pressure from commodity costs.
The 20.0% increase in international revenue helped lift consolidated growth above the standalone revenue growth rate of 8.9%. But Dabur has also referred to international market volatility, meaning overseas growth is being delivered in an uncertain operating backdrop. The company did not disclose country-level international figures in the provided results summary.
The interim dividend of ₹3.50 per share gives shareholders a direct distribution following the quarter. The disclosed approval for the Sesa Care amalgamation is another corporate development for investors to track, although the provided information does not state the financial effect of the transaction.
Conclusion
Dabur delivered Q2 FY27 consolidated revenue growth of 11.6% to ₹3,563 crore and PAT growth of 11.7% to ₹505 crore. Domestic FMCG volume growth, stronger international revenue and continued momentum in personal-care categories supported the result, while inflation contributed to a 60-basis-point operating-margin contraction.
The next disclosed event is Dabur's analyst and institutional investor meet in Mumbai on November 5, 2026. Investors will watch for management's comments on FY27 demand, commodity-cost pressures, pricing and cost-saving measures, overseas-market conditions, and the progress of the Sesa Care amalgamation.


